improving treatment for patients with tp53-mutated myeloid malignancies
Published 1 month ago • 56 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
1:27
treatment options for patients with tp53-mutated aml
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
1:39
treatment approaches for patients with tp53m aml ineligible for high intensity chemotherapy
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
3:56
treatment approaches for patients with tp53-mutated mcl
-
1:26
updates in the treatment landscape of p53-mutated aml/mds
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
2:57
novel targeted therapies for the treatment of bpdcn
-
1:59
depth of molecular response in patients with tp53m mds & aml treated with magrolimab and azacitidine
-
1:13
the challenges of treating patients with mpns who possess a tp53 mutation
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
0:58
options available to patients with tp53-mutated mds beyond stem cell transplantation
-
8:14
progress in the treatment of tp53 mutated aml
-
1:57
the benefit of allogeneic transplantation in patients with tp53-mutated aml
-
2:24
the challenges of treating tp53-mutated aml and mds
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
1:27
tp53-aberrant mcl: challenges and treatment approaches
-
0:59
the treatment of patients with t(11;14) myeloma